Specifically, we performed the analysis in mice engineered to have liver-specific elevation of AF6 expression (Supplementary Fig. 5a–c), suggesting that AF6 modulates the occurrence of necroptosis in these additional liver diseases. This evidence concerns the gene AFDN and liver disorder.